Predict your next investment

Stelis Biopharma company logo
HEALTHCARE | Drug Development
stelis.com

See what CB Insights has to offer

Stage

Series C | Alive

Total Raised

$195M

Valuation

$0000 

Last Raised

$125M | 6 mos ago

About Stelis Biopharma

Stelis Biopharma is a vertically integrated biopharmaceutical company with R&D, process scale-up and end-to-end manufacturing capabilities from drug substance to finished drug products in all injectable formats.

Stelis Biopharma Headquarter Location

#293, Jigani Link Road, Bommasandra, Anekal Taluk

Bengaluru, 560 105,

India

+91 80 6784 0444

Latest Stelis Biopharma News

Stelis Biopharma appoints Mark W. Womack as CEO

Aug 7, 2021

Stelis Biopharma appoints Mark W. Womack as CEO Published On: Sat, Aug 7th, 2021 Stelis Biopharma Limited, a biopharma and vaccines company and the biotech arm of Strides Pharma Science has appointed Mark W. Womack as its new chief executive officer (CEO). Mark W. Womack is also the designated managing director and will be inducted to the board of directors later depending on the required statutory clearances and processes. As the CEO and MD of Stelis Biopharma, Mark W. Womack will be responsible for driving an aggressive growth and profitability strategy for the company in its business streams, which include global contract development and manufacturing organization (CDMO) services and the development of the biosimilars pipeline and integrated vaccines play. Photo courtesy of Free-Photos from Pixabay. Mark W. Womack will also take care of the company’s overall strategy and provide leadership to research and development, business development, manufacturing, and commercial operations. Arun Kumar — Founder of Strides Group said: “We are delighted to onboard Mark as the new CEO of Stelis. Stelis stands on the cusp of a transition to become a globally recognized biopharmaceutical company while targeting significant growth in the coming years. “Mark’s strong background in commercial leadership, rich management consulting experience, and network within the biotech CDMO space make him exceptionally well suited to drive this transition for Stelis. “We are confident that together Mark and his leadership team will take Stelis through the next level of growth, profitability and industry-leading reputation.” Related

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Stelis Biopharma

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Stelis Biopharma is included in 2 Expert Collections, including Pharma Startups.

P

Pharma Startups

6,549 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

B

Biopharmaceuticals

5,732 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

Stelis Biopharma Patents

Stelis Biopharma has filed 5 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Proteins
  • Biochemistry methods
patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/27/2016

10/16/2018

Diabetes, Peptide hormones, Proteins, Molecular biology, Insulin therapies

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/27/2016

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

10/16/2018

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Diabetes, Peptide hormones, Proteins, Molecular biology, Insulin therapies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Stelis Biopharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Stelis Biopharma Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.